Philippe Bégin Selected Research

Philippe Bégin Research Topics

Disease

23	Hypersensitivity (Allergy) 03/2024 - 03/2012
14	Food Hypersensitivity (Food Allergy) 05/2024 - 06/2013
10	COVID-19 05/2023 - 10/2020
7	Anaphylaxis (Anaphylactic Shock) 05/2023 - 01/2018
6	Peanut Hypersensitivity (Peanut Allergy) 05/2023 - 01/2019
4	Inflammation (Inflammations) 11/2023 - 03/2022
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 10/2022
3	Asthma (Bronchial Asthma) 01/2021 - 06/2007
3	Egg Hypersensitivity (Egg Allergy) 01/2018 - 01/2016
2	Atherosclerotic Plaque (Atheroma) 11/2023 - 08/2023
2	Viremia 11/2023 - 08/2023
2	Premature Aging 11/2023 - 08/2023
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 08/2023
2	Convalescence 01/2021 - 01/2021
2	Coinfection 01/2021 - 01/2021
1	Milk Hypersensitivity (Milk Allergy) 02/2024
1	Eczema 12/2023
1	Eosinophilic Esophagitis 01/2023
1	Multiple Organ Failure (MODS) 03/2022
1	Yellow Fever 11/2021
1	Infections 05/2021
1	Transfusion Reaction 05/2021
1	Body Weight (Weight, Body) 01/2021
1	Vomiting 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Human Influenza (Influenza) 01/2020
1	Drug Eruptions (Drug Eruption) 12/2017
1	Atopic Dermatitis (Atopic Eczema) 11/2013
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 07/2013
1	Drug Hypersensitivity Syndrome 07/2013
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2013
1	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 01/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2012
1	Nicolau Syndrome 03/2012

Drug/Important Bio-Agent (IBA)

10	Immunoglobulin E (IgE)IBA 02/2024 - 01/2013
8	AllergensIBA 05/2024 - 01/2014
8	VaccinesIBA 05/2023 - 03/2012
5	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2018
5	Penicillins (Penicillin)FDA Link 01/2020 - 03/2012
4	AntibodiesIBA 11/2023 - 01/2021
3	Omalizumab (Xolair)FDA Link 04/2024 - 02/2014
3	CytokinesIBA 11/2023 - 10/2022
3	COVID-19 VaccinesIBA 05/2023 - 09/2022
3	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022 - 07/2013
2	Glycoproteins (Glycoprotein)IBA 03/2024 - 08/2023
2	dupilumabIBA 01/2023 - 01/2023
2	Oxygen (Dioxygen)IBA 11/2021 - 05/2021
2	Penicillin G (Benzylpenicillin)FDA LinkGeneric 01/2020 - 07/2014
2	penicilloyl polylysineIBA 01/2020 - 07/2014
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2020 - 12/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2014 - 05/2013
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Abatacept (Orencia)FDA Link 01/2023
1	Vaccine ExcipientsIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	Excipients (Suspending Agents)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 03/2022
1	Bisoprolol (Concor)FDA LinkGeneric 05/2021
1	Blood Group Antigens (Blood Groups)IBA 05/2021
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 11/2019
1	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2019
1	beta-LactamsIBA 11/2019
1	Therapeutic UsesIBA 05/2014
1	anti-IgE antibodiesIBA 11/2013
1	Ceftazidime (Fortum)FDA LinkGeneric 07/2013
1	beta Lactam AntibioticsIBA 05/2013
1	Infliximab (Remicade)FDA Link 04/2013
1	galsulfase FDA Link 01/2013
1	Interleukin-33IBA 12/2012
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2007

Therapy/Procedure

18	Immunotherapy 03/2024 - 01/2014
8	Therapeutics 11/2023 - 04/2013
2	Critical Care (Surgical Intensive Care) 01/2023 - 05/2021
2	Length of Stay 05/2021 - 01/2020
1	Art Therapy 08/2023
1	Mechanical Ventilators (Ventilator) 05/2021